Cargando…
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
Pulmonary aspergillosis has been increasingly reported following severe respiratory viral infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at-risk for COVID-19 associated pulmonary aspergillosis (CAPA). Prompt recognition of this syndrome and is paramount to i...
Autores principales: | Thompson III, George R, Cornely, Oliver A, Pappas, Peter G, Patterson, Thomas F, Hoenigl, Martin, Jenks, Jeffrey D, Clancy, Cornelius J, Nguyen, M Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337819/ https://www.ncbi.nlm.nih.gov/pubmed/32754626 http://dx.doi.org/10.1093/ofid/ofaa242 |
Ejemplares similares
-
Treatment of Aspergillosis
por: Jenks, Jeffrey D., et al.
Publicado: (2018) -
The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020) -
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018) -
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020) -
257. Aspergillus Galactomannan Lateral Flow Assay for Rapid Diagnosis of Invasive Aspergillosis in Bronchoalveolar Lavage
por: Hoenigl, Martin, et al.
Publicado: (2019)